Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. - Wikidata - wikimedia - TriplyDB

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.

http://www.wikidata.org/entity/Q39940045

about

Diabetic neuropathic pain: Physiopathology and treatment Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Painful diabetic neuropathy: advantage of novel drugs over old drugs?A study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy.Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Treating pain in multiple sclerosis.Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Update on the management of diabetic polyneuropathies.Pharmacological treatment of diabetic peripheral neuropathy.Systemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model.Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy.A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain.Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.Pregabalin in neuropathic pain: evidences and possible mechanisms.Emerging drugs for diabetic neuropathy.Review of current guidelines on the care of postherpetic neuralgia.Drug safety evaluation of pregabalin.Management of painful diabetic neuropathy: guideline guidance or jungle?What is the role of sedating antidepressants, antipsychotics, and anticonvulsants in the management of insomnia?Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species.Diabetic neuropathy and oxidative stress: therapeutic perspectives.Pharmacologic management of diabetic peripheral neuropathic pain.Vaccination against and treatment of acute herpes zoster for prevention of post-herpetic neuralgia.Pain in chronic kidney disease: a scoping review.Neurologic complications of diabetes.Recent advances in the management of diabetic distal symmetrical polyneuropathy Management options for established chemotherapy-induced peripheral neuropathy.Diagnosis and management of neuropathic pain.Evaluating the Phase II drugs currently under investigation for diabetic neuropathy.Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: a randomized, placebo-controlled trial.Understanding and treating painful diabetic neuropathy: time for a paradigm shift.

P2860

Q27004604-D363F87B-455B-45B4-A57C-15EA6D5F03A4 Q30537158-913A8B79-21B2-4040-A007-FFD98E544D4E Q31170335-93D08D47-9B97-427E-A957-DAC805A1ED92 Q33408025-E718DFA6-16B6-4825-8742-E49C9E3893BC Q33610824-DF02007F-2CC6-4B1C-A5AB-7DF564BCD4D7 Q33747072-11028024-B185-4AE1-AAA5-319FA6E076DF Q33921692-0B14AC1F-BCB8-4B52-B3F3-FB7ED1D641A5 Q33949565-FFAD915D-DCA4-467B-A13A-82CE079A44DF Q34110857-27AF6271-F7E4-4F96-9472-DEB46152D33F Q34153575-B326A212-10F2-4C27-9439-2996232A1E60 Q34411257-CCBBC323-9EAD-4191-A7FF-004568BDCB17 Q34632301-AF26F658-7FCB-41D6-A6DC-BD8F88C421B2 Q34655586-6BEA486F-F9B7-4A22-991A-45F3851475A1 Q35061149-81B09218-8F18-4C9F-8DC8-1D328A7F173B Q35178801-4FDB5159-A54A-4FAD-BD35-A9564203E870 Q35669997-3B3BAC1E-1481-47B6-9CD2-EF17598127CE Q36087104-10F71BD1-305E-41C6-ADB2-BA03FB230241 Q36329924-D8B57132-A635-4DF8-923C-9CBAA2F3EE06 Q36538217-C1292068-38DF-4309-92BF-76D45737A407 Q36659712-89B4CE7A-3731-400E-80FA-8C368B6AF70D Q36701353-0586C2AC-87A0-459D-B6E8-F00ECAAD2386 Q37495207-CD283405-7F33-42F6-A9AE-DA64043F1FFA Q37559818-0A196F0A-1901-42EA-996D-D49962830C0A Q37783301-297698B2-F8C6-434B-BF87-C1F4F25AB1DF Q37929504-56D7313A-32CA-4CAF-8815-C3162CAFC3A2 Q37999052-78711FE0-41B4-4908-B7E2-EFCF6089AF5D Q38012664-27B72E55-A1B9-4BF4-BD9C-47D7BF6A3F05 Q38038079-4787AC66-F4D5-46AE-8E12-4BCF28A7322E Q38110740-53075F3D-0411-426F-BAC1-2677BD2A1B6A Q38112117-A9A7AA07-0C59-45DA-BA3C-395BB3F191DF Q38116975-13654F45-A617-4933-BF77-87D6DF73D16A Q38133446-E530D957-144E-4B8F-88DA-3C77511C62F7 Q38187185-A8E6948F-A288-4941-9FE4-6AE997ADDCD3 Q38210942-238C8489-7911-4026-A46D-D10BF2D33F97 Q38213043-E2ABF4D2-9B26-4F05-B7A1-43139B02EF67 Q38216217-7B1FA8DB-11FD-4B7C-89A0-448AB614572E Q38222253-59917E7F-1DCD-43EF-B3C4-5674B0648BCE Q38244605-59CCEEF5-7F07-4BE7-829C-85A3FA89D6DC Q38373631-E52E35A4-7F4D-44C0-8EE0-75C5C0B4D2FA Q38394422-EABF7C93-B9D9-40FF-8534-00119FCB24E0

P2860

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.

http://www.wikidata.org/entity/Q39940045

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@en

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@nl

type

label

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@en

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@nl

prefLabel

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@en

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@nl

P1433

Q39940045-68AFC249-85C7-428B-8B70-0122C6F4A540

P1476

Q39940045-31F99B7F-A3B3-4964-AE26-4205EE366E8F

P2093

Q39940045-35AD56BB-C0B5-4A05-8475-1465D3D583F4

Q39940045-C9FF0275-4BD0-4E62-992E-0254666DE9F2

Q39940045-D2FEBEFC-73E4-48CB-BBCF-9A3B8CF114D2

P2860

Q39940045-0C06F8DA-9E6C-4A50-A69D-9DD04EBCE6F1

Q39940045-12A904CE-3725-4CC5-B04D-F141B86E9FB6

Q39940045-13991048-F526-4737-A494-D4AC4E90D388

Q39940045-140CA4B4-A0C0-4D93-85EE-DE21886C816B

Q39940045-3C30CD75-0E1D-4BB6-A8B0-59F07D38E480

Q39940045-4714F3AB-852E-4469-9169-9EBA01AA6843

Q39940045-50927419-3087-4FF1-9D1F-EE81A15F9FF2

Q39940045-61A0092C-FCF7-46F3-B6F5-A0063862D736

Q39940045-873D5100-6723-4E02-B962-E5815F3967FD

Q39940045-8748031B-02DF-41EC-9F55-BBE2C0932BDD

P304

Q39940045-358FAFF1-9823-4EFE-A33E-F5115BC1B4BC

P31

Q39940045-AD09977A-7340-4B9F-87B4-D5265BFCBA39

Q39940045-cd92dfb4-1c04-4882-925a-3a4588e4bb1f

P356

Q39940045-8CFA31DF-6B69-49A0-BD74-2EAB2C2603C7

P407

Q39940045-AC59FD92-B22E-42D7-AC2C-DEB6E424F3D6

P433

Q39940045-E379D4B6-3C1D-4D90-B147-AB16F69EACCC

P478

Q39940045-4751D341-4FC4-4BA0-AAA7-90DB49C36062

P577

Q39940045-13EAC1E4-EBF3-454B-8D44-2A5D824762E4

P5875

Q39940045-A6600CD4-E9C4-4CC4-9738-48CFCE4D404B

P698

Q39940045-5CE8A35C-E401-423A-B340-8B19880FE5FB

P932

Q39940045-CD36C37F-FC87-4493-A1B5-8F3E61E40315

P356

P1433

P1476

Efficacy, safety, and tolerabi ...... rials across a range of doses.

@en

P2093

Birol Emir

http://www.w3.org/2001/XMLSchema#string

Edith Durso-Decruz

http://www.w3.org/2001/XMLSchema#string

Roy Freeman

http://www.w3.org/2001/XMLSchema#string

P2860

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.

Diabetic neuropathies: a statement by the American Diabetes Association.

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.

P304

1448-1454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC07-2105

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5496861

http://www.w3.org/2001/XMLSchema#string

P698

18356405

http://www.w3.org/2001/XMLSchema#string

P932

2453685

http://www.w3.org/2001/XMLSchema#string